NCT01327599

Efficacy of Changing to DUOTRAV® From Prior Therapy

Assessing the Efficacy and Tolerability of Changing to DUOTRAV® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to assess the efficacy and tolerability of changing to DUOTRAV® from prior bimatoprost 0.03%/timolol 0.5% pharmacotherapy in subjects with open-angle glaucoma or ocular hypertension having uncontrolled intraocular pressure (IOP).

Conditions

• Open-Angle Glaucoma
• Ocular Hypertension
• Pigment Dispersion Glaucoma

Interventions

Type	Name	Description
DRUG	Travoprost 0.004%+Timolol 0.5% ophthalmic solution	Fixed dose combination topical ocular agent preserved with polyquaternium-1 (POLYQUAD)

Timeline

• Start date: 2011-08-01
• Primary completion: 2012-11-01
• Completion: 2012-11-01
• First posted: 2011-04-01
• Last updated: 2014-02-10
• Results posted: 2014-01-10